Medical Devices Growth Investors & VC Firms

523 firms in this list, with a median first check of $1.1M. 130 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
MO Montreux Equity Partners DKHDJJ3 people	88🔒	San Francisco	US	Growth	$10M – $20M	+ Add to CRM
XB XB Ventures AFFDHVJA7 people	88🔒	—		Growth	—	+ Add to CRM
FI Fir Capital AEGMMUDT8 people · Follows rounds	88🔒	Nova Lima	BR	Seed–Growth	$100K – $5M	+ Add to CRM
VE Vesalius Biocapital Partners APCSGMGG5 people · Leads rounds	88🔒	Luxembourg	LU	Seed–Growth	$11M	+ Add to CRM
HI HighCape Capital KRMZCRCH7 people	88🔒	Westport	US	Growth	—	+ Add to CRM
CL Clal Biotechnology Industries AALNNMAF8 people	88🔒	Tel Aviv	IL	Seed–Late Stage	—	+ Add to CRM
GA Galen Partners BWDNZSLJ7 people	88🔒	Stamford	US	Growth	—	+ Add to CRM
HE Healthcare Venture Partners, Llc JCMYELJD10 people	88🔒	Charleston	US	Series B–Late Stage	—	+ Add to CRM
KE Kendall Capital Partners DZJBDRGM7 people	88🔒	Boston	US	Seed–Growth	—	+ Add to CRM
KI KIC Ventures VLAWECJS10 people	88🔒	Fort Lauderdale	US	Growth–Late Stage	—	+ Add to CRM
VE Vertex Ventures HC CBLHYLJS4 people	88🔒	Singapore	SG	Seed–Growth	$500K – $10M	+ Add to CRM
SI Sirius Venture Partners GmbH FVMBASJS8 people	88🔒	Wiesbaden	DE	Seed–Growth	$540K – $5.4M	+ Add to CRM
VE Vesalius Biocapital III Partners SàRL CSGGMLSV11 people	88🔒	Contern	LU	Series B–Late Stage	$10.8M	+ Add to CRM
WA Waarde Capital BPAHJLAS5 people	88🔒	Capellen	LU	Seed–Growth	$15M	+ Add to CRM
SP Split Rock Partners JSMGSZDS4 people · Leads rounds	88🔒	Eden Prairie	US	Seed–Growth	$2M – $40M	+ Add to CRM
DE Device of Tomorrow Capital HYDO2 people	88🔒	—		Seed–Growth	—	+ Add to CRM
AU Australis Partners AMABCCEB8 people	88🔒	New York	US	Growth	—	+ Add to CRM
KE Kern Capital, LLC JK1 person · Leads rounds	88🔒	Larkspur	US	Series A–Late Stage	$5M – $15M	+ Add to CRM
BL Blue Highway Capital CJKGOFRP7 people	88🔒	Philadelphia	US	Growth	$3M – $8M	+ Add to CRM
AB ABS Ventures BBBGSA3 people	88🔒	Waltham	US	Growth	—	+ Add to CRM
SO Southern Cross Venture Partners BCJSJWMB4 people	88🔒	Narrabeen	AU	Seed–Growth	$1.3M – $6.6M	+ Add to CRM
NE Newlin Investment Company LLC WRSNCA3 people	88🔒	Pittsburgh	US	Growth	$100K – $3M	+ Add to CRM
OX Oxford Investment Consultants LLP CAGRPLCH9 people	88🔒	Oxford	GB	Seed–Growth	—	+ Add to CRM
WH Whiz Partners Inc. YH安俊藤朋HF6 people	88🔒	Tokyo	JP	Seed–Late Stage	$500K – $5M	+ Add to CRM

Montreux Equity Partners

San FranciscoGrowth$10M – $20M

DKHDJJ3 people

XB Ventures

Growth

AFFDHVJA7 people

Fir Capital

Nova LimaSeed–Growth$100K – $5M

AEGMMUDT8 people

Vesalius Biocapital Partners

LuxembourgSeed–Growth$11M

APCSGMGG5 people

HighCape Capital

WestportGrowth

KRMZCRCH7 people

Clal Biotechnology Industries

Tel AvivSeed–Late Stage

AALNNMAF8 people

Galen Partners

StamfordGrowth

BWDNZSLJ7 people

Healthcare Venture Partners, Llc

CharlestonSeries B–Late Stage

JCMYELJD10 people

Kendall Capital Partners

BostonSeed–Growth

DZJBDRGM7 people

KIC Ventures

Fort LauderdaleGrowth–Late Stage

VLAWECJS10 people

Vertex Ventures HC

SingaporeSeed–Growth$500K – $10M

CBLHYLJS4 people

Sirius Venture Partners GmbH

WiesbadenSeed–Growth$540K – $5.4M

FVMBASJS8 people

Vesalius Biocapital III Partners SàRL

ConternSeries B–Late Stage$10.8M

CSGGMLSV11 people

Waarde Capital

CapellenSeed–Growth$15M

BPAHJLAS5 people

Split Rock Partners

Eden PrairieSeed–Growth$2M – $40M

JSMGSZDS4 people

Device of Tomorrow Capital

Seed–Growth

HYDO2 people

Australis Partners

New YorkGrowth

AMABCCEB8 people

Kern Capital, LLC

LarkspurSeries A–Late Stage$5M – $15M

JK1 person

Blue Highway Capital

PhiladelphiaGrowth$3M – $8M

CJKGOFRP7 people

ABS Ventures

WalthamGrowth

BBBGSA3 people

Southern Cross Venture Partners

NarrabeenSeed–Growth$1.3M – $6.6M

BCJSJWMB4 people

Newlin Investment Company LLC

PittsburghGrowth$100K – $3M

WRSNCA3 people

Oxford Investment Consultants LLP

OxfordSeed–Growth

CAGRPLCH9 people

Whiz Partners Inc.

TokyoSeed–Late Stage$500K – $5M

YH安俊藤朋HF6 people

Data sourced from public filings and firms' own websites — see our methodology.